| Hans-Günter Meyer-Thompson | Monatliche Neuheiten
96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial.
96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial.
Farrell M, Shahbazi J, Chambers M, Byrne M, Gholami J, Zahra E, Grebely J, Lintzeris N, Larance B, Ali R, Nielsen S, Dunlop A, Dore GJ, McDonough M, Montebello M, Weiss R, Rodgers C, Cook J, Degenhardt L; CoLAB study team.
Int J Drug Policy. 2024 Mar 23;127:104390. doi: 10.1016/j.drugpo.2024.104390. Epub ahead of print. PMID: 38522175.
https://www.sciencedirect.com/science/article/pii/S0955395924000756